Tryptophan depletion and depressive vulnerability

Biological Psychiatry

Volumn 46, Issue 4, 1999, Pages 498-505

  Moreno, Francisco A ^a   Gelenberg, Alan J ^a   Heninger, George R ^b   Potter, Rebecca L ^a   McKnight, Katherine M ^c   Allen, John ^a   Phillips, Aleksandra P ^d   Delgado, Pedro L ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Center of Excellence in Substance Abuse Treatment and Education   (United States)

^d TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Depletion; Depression; Prediction; Serotonin; Tryptophan; Vulnerability

Indexed keywords

ALPRAZOLAM; AMINO ACID MIXTURE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; COCAINE; FLUOXETINE; NEFAZODONE; PLACEBO; SEROTONIN; SERTRALINE; TRYPTOPHAN;

ADULT; AGED; ANIMAL EXPERIMENT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPLETION; DEPRESSION; DOUBLE BLIND PROCEDURE; FAMILY HISTORY; FEMALE; HUMAN; MALE; MOOD; OBSESSION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ADULT; AGED; BIOLOGICAL MARKERS; CROSS-OVER STUDIES; DEPRESSION; DOUBLE-BLIND METHOD; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MOOD DISORDERS; PSYCHIATRIC STATUS RATING SCALES; RECURRENCE; SEROTONIN; SEX CHARACTERISTICS; TRYPTOPHAN;

EID: 0032794192     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(99)00095-5     Document Type: Article

References (43)

1. Diagnostic and Statistical Manual of Mental Disorders. 3rd ed., rev. 1987;American Psychiatric Association, Washington, DC.
2. Anderson G.M., Young J.G., Cohen D.J., Schlicht K.R., Patel N. Liquid-chromatographic determination of serotonin and tryptophan in whole blood and plasma. Clin Chem. 27:(5):1981;775-776.
3. Barr L.C., Goodman W.K., McDougle C.J., Delgado P.L., Heninger G.R., Charney D.S., et al. Tryptophan depletion in patients with obsessive-compulsive disorder who respond to serotonin reuptake inhibitors. Arch Gen Psychiatry. 51:(4):1994;309-317.
4. Barr L.C., Goodman W.K., Price L.H., McDougle C.J., Charney D.S. The serotonin hypothesis of obsessive-compulsive disorder Implications of pharmacological challenge studies . J Clin Psychiatry. 53:(4 suppl):1992;17-28.
5. Bel N., Artigas F. Reduction of serotonin function in rat brain by tryptophan depletion Effects in control and fluvoxamine-treated rats . J Neurochem. 67:(2):1996;669-676.
6. Benkelfat C., Seletti E., Mark A., Dean P., Palmour R.M., Young S.N. Mood-lowering effects of tryptophan depletion Enhanced susceptibility in young man at genetic risk for major affective disorders . Arch Gen Psychiatry. 51:1994;687-697.
7. Biggio G., Fadda F., Fani P., Tagliamonte A., Gessa G.L. Rapid depletion of serum tryptophan, brain tryptophan, serotonin, and 5-hydroxyindoleacetic acid by a tryptophan-free diet. Life Sci. 14:1974;1321-1329.
8. Blier P., de Montigny C., Chaput Y. A role for the serotonin system in the mechanism of action of antidepressant treatments Preclinical evidence . J Clin Psychiatry. 51:(4 suppl):1990;14-20.
9. Bremner J.D., Innis R.B., Solomon R.M., Stain L.H., Nn C.K., Miller H.L., et al. Positron emission tomography measurement of cerebral metabolic correlates of tryptophan depletion-induced depressive relapse. Arch Gen Psychiatry. 54:1997;364-374.
10. Carpenter L.L., Anderson G.M., Pelton G.H., Gudin J.A., Kirwin P.D., Price L.H., et al. Tryptophan depletion during continuous CSF sampling in healthy human subjects. Neuropsychopharmacology. 19:1998;26-35.
11. Curzon G. Relationships between plasma, CSF and brain tryptophan. J Neural Transm Suppl. 15:1979;93-105.
12. Curzon G. Influence of plasma tryptophan on brain 5-HT synthesis and serotonergic activity. Haber B., Gabay S. Serotonin Current Aspects of Neurochemistry and Function . 1981;207-219 Plenum Press, New York, London.
13. Delgado P.L., Charney D.S., Price L.H., Aghajanian G.K., Landis H., Heninger G.R. Serotonin function and the mechanism of antidepressant action Reversal of antidepressant induced remission by rapid depletion of plasma tryptophan . Arch Gen Psychiatry. 47:1990;411-418.
14. Delgado PL, Gelenberg AJ, Bologna L (1994): Serotonin depletion in paroxetine treated panic disordered patients. Presented at the 147th Annual Meeting of the American Psychiatric Association, New research abstract #616, May.
15. Delgado PL, Moreno FM, Miller HM, Salomon RM, Licinio J, Krystal JH, et al (1999): Tryptophan depletion challenge in depressed patients treated with desipramine or fluoxetine: Implications for the role of serotonin in the mechanism of antidepressant action. Biol Psychiatry, in press.
16. Delgado P.L., Price L.H., Aghajanian G.K., Miller H.M., Salomon R.M., Heninger G.R., et al. Serotonin and the neurobiology of depression Effects of tryptophan depletion in drug-free depressed patients . Arch Gen Psychiatry. 51:1994;865-874.
17. Delgado P.L., Price L.H., Miller H.M., Salomon R.M., Licinio J., Krystal J.H., et al. Rapid serotonin depletion as a provocative challenge test for patients with major depression Relevance to antidepressant action and the neurobiology of depression . Psychopharmacol Bull. 27:(3):1991;321-330.
18. Ellenbogen M.A., Young S.N., Dean P., Palmour R.M., Benkelfat C. Mood response to tryptophan depletion in healthy volunteers Sex differences and temporal stability . Neuropsychopharmacology. 15:(5):1996;465-474.
19. Fernstrom J.D. Effects of the diet on brain neurotransmitters. Metabolism. 26:(2):1977;207-223.
20. Gessa G.L., Biggio G., Fada F., Corsini G.V., Tagliamonte A. Effects of oral administration of tryptophan-free amino acid mixtures on serum tryptophan, brain tryptophan and serotonin metabolism. J Neurochem. 22:1974;869-870.
21. Goddard A.W., Sholomskas D.E., Walton K.E., Francine M., Charney D.S., Heninger G.R., et al. Effects of tryptophan depletion in panic disorder. Biol Psychiatry. 36:(11):1994;775-777.
22. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol. 32:1959;51-53.
23. Krahn L.E., Lu P.Y., Klee G., Delgado P.L., Lin S.C., Zimmerman R.C. Examining serotonin function A modified technique for tryptophan depletion . Neuropsychopharmacology. 15:1996;325-328.
24. Lam R.W., Zis A.P., Grewal A., Delgado P.L., Charney D.S., Krystal J.H. Effects of rapid tryptophan depletion in patients with seasonal affective disorder in remission after light therapy. Arch Gen Psychiatry. 53;1:1996;41-44.
25. Leyton M., Young S.N., Blier P., Ellenbogen M.A., Palmour R.M., Ghadirian A.M., et al. The effect of tryptophan depletion on mood in medication-free, former patients with major affective disorder. Neuropsychopharmacology. 16:1997;292-297.
26. Mazure C.M., Nelson J.C., Price L.H. Reliability and validity of the symptoms of major depressive illness. Arch Gen Psychiatry. 43:1986;451-456.
27. McNair D.M., Lorr M., Droppleman L.F. Manual for the Profile of Mood States. 1988;Educational and Industrial Testing Service, San Diego.
28. Moja E.A., Cipollo P., Castoldi D., Tofanetti O. Dose-response decrease in plasma tryptophan and in brain tryptophan and serotonin after tryptophan-free amino acid mixtures in rats. Life Sci. 44:1989;971-976.
29. Moja E.A., Restani P., Corsini E., Stacchezzini M.C., Assereto R., Galli C.L. Cycloheximide blocks the fall of plasma and tissue tryptophan levels after tryptophan-free amino acid mixtures. Life Sci. 49:1991;1121-1128.
30. Moreno FA, McGavin C, Malan P, Gelenberg AJ, Heninger GR, Mathe AA, et al (1997): CSF monoamine metabolites during tryptophan depletion in healthy males. American College of Neuropsychopharmacology Annual Meeting. Scientific abstracts page #253.
31. Murphy D.L., Campbell I., Costa J.L. Current status of the indoleamine hypothesis of the affective disorders. Lipton M.A., DiMascio A., Killan F. Psychopharmacology A Generation of Progress . 1978;1235-1247 Raven Press, New York.
32. Neumeister A., Praschak-Rieder N., Heßelman B., Rao M.L., Gluck J., Kasper S. Effects of tryptophan depletion on drug-free patients with seasonal affective disorder during a stable response to bright light therapy. Arch Gen Psychiatry. 54:1997;133-138.
33. Nishizawa S., Benkelfat C., Young S.N., Leyton M., Mzengeza S., de Montigny C., et al. Differences between males and females in rates of serotonin synthesis in human brain. Proc Natl Acad Sci U S A. 94:1997;5308-5313.
34. Rose W.C., Haines W.J., Warner D.T. The amino acid requirements of man. J Biol Chem. 206:(1):1954;421-430.
35. Rush J.A., Giles D.E., Sclesser M.A., Fulton C.L., Wissenberg J., Burns C. The inventory for depressive symptomatology (IDS) Preliminary findings . Psychiatry Res. 18:(1):1986;65-87.
36. Satel S.L., Krystal J.H., Delgado P.L., Kosten T.R., Charney D.S. Tryptophan depletion and attenuation of cue-induced craving for cocaine. Am J Psychiatry. 152:(5):1995;778-783.
37. Smith K.A., Fairburn C.G., Cowen P.J. Relapse of depression after rapid tryptophan depletion. Lancet. 349:1997;915-919.
38. Spitzer R.L. Structured Clinical Interview for DSM III-R. 1987;Biometrics Research Department, New York State Psychiatric Institute, New York.
39. Wells K.B., Steward A., Hays R.D., Burnam M.A., Rogers W., Daniels M., et al. The functioning and well-being of depressed patients Results from the medical outcome study . JAMA. 262:1989;914-919.
40. Williams WA, Hommer DW, Shoaf S, Goldman DS, Geyer C, Linnoila MI (1997): Behavioral and biochemical effects of acute depletion of plasma tryptophan in patients with alcoholism and in normal volunteers. Annual Meeting of the American Psychiatric Association, New Research Abstract #165, San Diego, CA: May 17-22.
41. Woods S.W., Charney D.S., Goodman W.K., Heninger G.R. Carbon dioxide induced anxiety. Arch Gen Psychiatry. 45:1988;43-52.
42. Young S.N., Ervin F.R., Pihl R.O., Finn P. Biochemical aspects of tryptophan depletion in primates. Psychopharmacology. 98:(4):1989;508-511.
43. Young S.N., Smith S.E., Pihl R., Ervin F.R. Tryptophan depletion causes a rapid lowering of mood in normal males. Psychopharmacology. 87:1985;173-177.